Home › NDC Lookup › Ingredients › Balanced Salt Solution › 00065-0795-15
BSS balanced salt solution 6.4 mg/mL; .75 mg/mL; .48 mg/mL; .3 mg/mL; 3.9 mg/mL; 1.7 mg/mL Solution, 15 mL — NDC 00065-0795-15 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

BSS balanced salt solution 6.4 mg/mL; .75 mg/mL; .48 mg/mL; .3 mg/mL; 3.9 mg/mL; 1.7 mg/mL Solution, 15 mL — NDC 0065-0795-15 (Billing 00065-0795-15)

by Alcon Laboratories, Inc. · 15 mL in 1 BOTTLE

This is a package of 15 mL of BSS balanced salt solution 6.4 mg/mL; .75 mg/mL; .48 mg/mL; .3 mg/mL; 3.9 mg/mL; 1.7 mg/mL Solution from Alcon Laboratories, Inc., marketed since Mar 1969 and currently FDA-listed. It is the main listing for this product, which comes in 2 package sizes.

NDC 00065-0795-15
🏷️ FDA NDC (as labeled) 0065-0795-15 billing pads the labeler segment with a zero
This package
Contains15 mL Medicaid pays$8.04 / unit · 12 mo Per package$120.66 / 15 ml · Medicaid Pack sizes2 compare ↓
Main listing for product 0065-0795 · Also comes in: 500 ml 0065-0795-50
Rx only Brand On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Oct 1, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 0065-0795-15 alone.

Record
FDA NDC Directory package listing · Human prescription drug
Code segments
0065 labeler · 0795 product · 15 package
Package marketed since
Mar 28, 1969
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Billing quantity
15 mL per package
Barcode (UPC)
0300650795159
Medicaid fills, this package
2,944 prescriptions in the last four reported quarters
FDA record last changed
Oct 1, 2026
Past resolved recalls for this product (2)
Class II · Apr 13, 2022 · Terminated — cGMP deviations: Temperature abuse (Mckesson Medical-Surgical Inc. Corporate Office) · FDA recall D-1033-2022
Class II · Apr 13, 2022 · Terminated — cGMP deviations: Temperature abuse (Mckesson Medical-Surgical Inc. Corporate Office) · FDA recall D-1034-2022

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 0065-0795-15
Product NDC 0065-0795
11-digit billing NDC 00065079515
NCPDP billing unit ML — per mL (volume)
RxCUI 806392, 806396
UNII 451W47IQ8X, 660YQ98I10, M4I0D6VV5M, 02F3473H9O, 4550K0SC9B, 1Q73Q2JULR
UPC 0300650795159
Application # NDA020742
SPL Set ID 4bd4d59c-eb3b-4a5e-9eb7-ae95b0a92bea
Established class (EPC) Blood Coagulation Factor; Calculi Dissolution Agent; Cations; Increased Large Intestin
Physiologic effect Increased Coagulation Factor Activity; Increased Large Intestinal Motility
Chemical class Calcium; Divalent
DEA schedule Non-controlled
Marketing category NDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 1969-03-28
Route OPHTHALMIC
Dosage form SOLUTION
Substance SODIUM CHLORIDE; POTASSIUM CHLORIDE; CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; SODIUM ACETATE; SODIUM CITRATE
TE code (Orange Book) AT · RLD · RS

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 86803010002000
GPI class BSS
GCN Seq No 053979
GCN 21768
HICL code 026132
Ingredient (HICL) Balanced Salt Irrig Soln No.2
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q6
Therapeutic class — intermediate (HIC2) Ophthalmic Preparations
HIC3 code Q6E
Therapeutic class — specific (HIC3) Eye Irrigations
AHFS code 52:92.00.00
AHFS class Eent Drugs, Miscellaneous
FDB label name BSS EYE SOLUTION
FDB brand name Bss
Legend status F — Federal legend — prescription drug or device
Quick answers
  • GSN (GCN sequence number): 053979
  • GCN: 21768
  • GPI-14 (Medi-Span): 86803010002000
  • HICL (First Databank): 026132
  • AHFS class code: 52:92.00.00
  • RxCUI (RxNorm): 806392
Why two NDCs? The FDA registers this code as 0065-0795-15 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00065-0795-15. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Calcium class.

Drug family (ATC) Calcium, Electrolyte solutions, Acidifiers
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name BSS EYE SOLUTION Ingredient Balanced Salt Irrig Soln No.2

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo $8.04 $120.66 / 15 ml
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
00065-0795-15 You're viewing this Main listing 15 mL in 1 BOTTLE 1969-03-28 — Active
00065-0795-50 0065-0795-50 500 mL in 1 BOTTLE 1969-03-28 — Active

You're viewing the smallest of 2 pack sizes for this product.

In Medicaid, this is the most-dispensed pack of this product — about 83% of fills over the last four reported quarters. See all packs ↓

Pack size FAQ

What quantity is in this package?
This package contains 15 mL — 15 ml in 1 bottle.
How does this package differ from NDC 00065-0795-50?
Both are BSS balanced salt solution 6.4 mg/mL; .75 mg/mL; .48 mg/mL; .3 mg/mL; 3.9 mg/mL; 1.7 mg/mL Solution — the drug itself is identical. This page's package is the 15 mL one, while NDC 00065-0795-50 is the 500 ml package.
What NDC number is used to bill for this package of BSS balanced salt solution 6.4 mg/mL; .75 mg/mL; .48 mg/mL; .3 mg/mL; 3.9 mg/mL; 1.7 mg/mL Solution?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Bss 6.4 mg/mL; .75 mg/mL; .48 mg/mL; .3 mg/mL; 3.9 mg/mL; 1.7 mg/mLthis 00065-0795-15 Alcon 15 ml — AT FDA listed —
Bss 6.4 mg/mL; .75 mg/mL; .48 mg/mL; .3 mg/mL; 3.9 mg/mL; 1.7 mg/mL 00065-1795-04 Alcon 500 ml — AT FDA listed —
Balanced Salt 6.4 mg/mL; .75 mg/mL; .48 mg/mL; .3 mg/mL; 3.9 mg/mL; 1.7 mg/mL 00264-1945-10 B. 500 ml — AT Discontinued —
About this product: this is the brand-name version. Some generic versions are approved by the FDA, but we could not confirm current pharmacy availability from our pricing/market data.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
1969
On the market since
Mar 1969
📍
2026
Currently FDA-listed
57 years listed
🔒
·
Generic approved (availability unconfirmed)
see note
🔒Generic approved by FDA, but pharmacy availability is not confirmed

The FDA lists approved generic versions of this medicine, but that does not always mean a pharmacy can get one today. Patent rules, launch agreements, supply and pricing can affect when generics actually arrive.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII QTT17582CB
    A strong acid used to adjust and maintain the proper pH level in liquid medicines, ensuring stability and preventing breakdown of active ingredients.
  • UNII 55X04QC32I
    A strong alkaline chemical used to adjust and maintain the pH balance of liquid medicines. It helps keep the medicine stable and ensures it stays effective during storage.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

3 inactive ingredients listed in the exact product block matched to this NDC.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerAlcon Laboratories, Inc.
Application holderALCON LABORATORIES INC
FDA applicationNDA020742 (NDA)
Labeler code00065
First marketedMar 1969
Product typeHuman Prescription Drug
Portfolio55 products on file

More NDCs from Alcon Laboratories, Inc. labeler code 00065

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🤒 Adverse Reactions 🧬 Clinical Pharmacology 📦 How Supplied / Storage and Handling 📋 Description ⚠️ Precautions 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 31 words ▾

INDICATIONS AND USAGE For use as an extraocular and intraocular irrigating solution during ocular surgical procedure involving perfusion of the eye with an expected maximum duration of less than 60 minutes.

⏱️ Dosage and Administration 95 words ▾

DOSAGE AND ADMINISTRATION The adapter plug is designed to accept an irrigating needle. Tissues may be irrigated by attaching the needle to the DROP-TAINER ® bottle as explained below. External irrigation may be done without the irrigating needle.

Method of using Adapter Plug for LUER-LOK ® Hub Ophthalmic Irrigating Needle: 1. Aseptically remove DROP-TAINER bottle from blister by peeling paper backing. 2.

Snap on surgeon's sterile irrigation needle. Push until firmly in place and twist slightly. 3.

Test assembly for proper function before use. NOTE: LUER-LOK is a registered trademark of Becton, Dickinson and Company.

⚠️ Warnings 65 words ▾

WARNINGS • NOT FOR INJECTION OR INTRAVENOUS INFUSION. • Do not use unless product is clear, seal is intact, and container is undamaged. • Do not use if product is discolored or contains a precipitate. • SINGLE patient use only. The contents of this bottle should not be used in more than one patient. • This solution contains no preservative, unused contents should be discarded.

🤒 Adverse Reactions 35 words ▾

ADVERSE REACTIONS Irrigation or any other trauma to the corneal endothelium may result in corneal swelling or bullous keratopathy. Post-operative inflammatory reactions as well as incidents of corneal edema and corneal decompensation have been reported.

🧬 Clinical Pharmacology 18 words ▾

CLINICAL PHARMACOLOGY BSS Sterile Irrigating Solution is an isotonic solution for use in irrigating tissues of the eyes.

📦 How Supplied / Storage and Handling 80 words ▾

HOW SUPPLIED In 15 mL and 30 mL sterile DROP-TAINER bottles (consisting of a polypropylene bottle and LEUR-LOK ™ adapter plug with a white polypropylene closure) in a blister package. 15 mL in a 15 mL bottle: NDC 0065-0795-15 30 mL in a 30 mL bottle: NDC 0065-0795-30 STORAGE: Store at 36° - 77°F (2° - 25°C). Revised: May 2021 Alcon Distributed by: Alcon Laboratories , Inc. 6201 South Freeway Fort Worth, Texas 76134 USA © 2021 Alcon Inc. W300048945-0521

📋 Description 91 words ▾

DESCRIPTION BSS™ Sterile Irrigating Solution is a sterile balanced salt solution, each mL containing sodium chloride (NaCl) 0.64%, potassium chloride (KCl) 0.075%, calcium chloride dihydrate (CaCl 2 •2H 2 O) 0.048%, magnesium chloride hexahydrate (MgCl 2 •6H 2 O) 0.03%, sodium acetate trihydrate (C 2 H 3 NaO 2 •3H 2 O) 0.39%, sodium citrate dihydrate (C 6 H 5 Na 3 O 7 •2H 2 O) 0.17%, sodium hydroxide and/or hydrochloric acid (to adjust pH), and water for injection. The pH is approximately 7.5. The osmolality is approximately 300 mOsm/Kg.

⚠️ Precautions 103 words ▾

PRECAUTIONS Open under aseptic conditions only. Prior to use, check the following: tip should be firmly in place, irrigating needle should be properly seated; squeeze out several drops before inserting into anterior chamber. The needle should be removed from the anterior chamber prior to releasing pressure to prevent suction.

Studies suggest that intraocular irrigating solutions which are iso-osmotic with normal aqueous fluids should be used with caution in diabetic patients undergoing vitrectomy since intraoperative lens changes have been observed. There have been reports of corneal clouding or edema following ocular surgery in which BSS Sterile Irrigating Solution was used as an irrigating solution.

📄 Package Label / Principal Display Panel ~2 min read ▾

PRINCIPAL DISPLAY PANEL NDC 0065-0795-15 BSS™ Sterile Irrigating Solution (balanced salt solution) ALCON CONTENTS: 3 doz. 15mL Single Dose Bottles STORAGE: Store at 36° - 77°F (2° - 25°C). Rx Only Alcon Alcon Laboratories, Inc.

Fort Worth, Texas 76134 USA 300048944-0521 NDC 0065-0795-15 BSS ® Sterile Irrigating Solution (balanced salt solution) ALCON ® a Novartis company CONTENTS: 3 doz. 15mL Single Dose Bottles STORAGE: Store at 36° - 77°F (2° - 25°C). Rx Only Alcon ® Alcon Laboratories, Inc.

Fort Worth, Texas 76134 USA © 2002, 2013, 2015 Novartis 9012635-1115 NDC 0065-0795-15 BSS ® Sterile Irrigating Solution (balanced salt solution) STERILE UNLESS PACKAGE OPEN OR BROKEN 15 mL DROP-TAINER ® Bottle, SINGLE DOSE UNIT With Adapter for LUER-LOK ® Hub Irrigating Needle A sterile balanced salt solution for extraocular and intraocular use during procedures with an expected maximum duration of less than 60 minutes. Read enclosed insert. WARNINGS: • NOT FOR INJECTION OR INTRAVENOUSINFUSION. • Do not use unless product is clear, seal is intact and container is undamaged. • Do not use if blister or paper backing is damaged or broken. • Do not use if product is discolored or contains a precipitate. • SINGLE patient use only.

The contents of this bottle should not be used in more than one patient. • This solution contains no preservative, unused contents should be discarded. PRECAUTIONS: Open under aseptic conditions only. Rx Only Each mL contains: sodium chloride 0.64%, potassium chloride 0.075%, calcium chloride dihydrate 0.048%, magnesium chloride hexahydrate 0.03%, sodium acetate trihydrate 0.39%, sodium citrate dihydrate 0.17%, sodium hydroxide and/or hydrochloric acid (to adjust pH), and water for injection.

STORAGE: Store at 36° - 77°F (2° - 25°C). NOTE: LUER-LOK is a registered trademark of Becton, Dickinson & Co. Alcon Laboratories, Inc.

Fort Worth, Texas 76134 USA Alcon 9017036-0119 NDC 0065-0795-15 BSS ® Sterile Irrigating Solution (balanced salt solution) STERILE UNLESS PACKAGE OPEN OR BROKEN 15 mL DROP-TAINER ® Bottle, SINGLE DOSE UNIT With Adapter for LUER-LOK ® Hub Irrigating Needle A sterile balanced salt solution for extraocular and intraocular use during procedures with an expected maximum duration of less than 60 minutes. Read enclosed insert. WARNINGS: • NOT FOR INJECTION OR INTRAVENOUS INFUSION. • Do not use unless product is clear, seal is intact and container is undamaged. • Do not use if blister or paper backing is damaged or broken. • Do not use if product is discolored or contains a precipitate. • SINGLE patient use only.

The contents of this bottle should not be used in more than one patient. • This solution contains no preservative, unused contents should be discarded. PRECAUTIONS: Open under aseptic conditions only. Rx Only Each mL contains: sodium chloride 0.64%, potassium chloride 0.075%, calcium chloride dihydrate 0.048%, magnesium chloride hexahydrate 0.03%, sodium acetate trihydrate 0.39%, sodium citrate dihydrate 0.17%, sodium hydroxide and/or hydrochloric acid (to adjust pH), and water for injection.

STORAGE: Store at 36° - 77°F (2° - 25°C). NOTE: LUER-LOK is a registered trademark of Becton, Dickinson & Co. Alcon Laboratories, Inc.

Fort Worth, Texas 76134 USA ©2003, 2013,2015 Novartis Alcon ® a Novartis company 9012632-1115 NDC 0065-0795-15 BSS ® STERILE IRRIGATING SOLUTION (BALANCED SALT SOLUTION) UNIT DOSE 15 mL Rx Only ALCON LABORATRIES, INC. FORT WORTH TEXAS 76134 USA 289010-0902

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
2.9K
Units reimbursed last 4 qtrs
26.8K
Gross reimbursed last 4 qtrs
$215.9K
Avg / prescription
$73.33
Avg / unit
$8.0443
Latest quarter Q1 2026
531Rx
Fee-for-service vs managed care ⓘ
23% FFS 77% MCO
Fee-for-service · 672 Rx Managed care · 2,272 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 13 units · 0.2 per 100k residents MN Wisconsin: 10,344 units · 175 per 100k residents WI Michigan: no data reported MI New York: 520 units · 2.7 per 100k residents NY Vermont: 67 units · 10.4 per 100k residents VT New Hampshire: 571 units · 40.7 per 100k residents NH Oregon: no data reported OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: 42 units · 4.6 per 100k residents SD Iowa: no data reported IA Illinois: no data reported IL Indiana: no data reported IN Ohio: 295 units · 2.5 per 100k residents OH Pennsylvania: 1,478 units · 11.4 per 100k residents PA New Jersey: 2,407 units · 25.9 per 100k residents NJ Massachusetts: 672 units · 9.6 per 100k residents MA California: 943 units · 2.4 per 100k residents CA Utah: no data reported UT Colorado: no data reported CO Nebraska: no data reported NE Missouri: 4,053 units · 65.4 per 100k residents MO Kentucky: 1,882 units · 41.6 per 100k residents KY West Virginia: no data reported WV Virginia: 1,016 units · 11.7 per 100k residents VA Maryland: no data reported MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: no data reported AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: 70 units · 1.0 per 100k residents TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: 760 units · 16.6 per 100k residents LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: 1,705 units · 119 per 100k residents HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
0.2175
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Wisconsin 175 /100k
2 Hawaii 119 /100k
3 Missouri 65.4 /100k
4 Kentucky 41.6 /100k
5 New Hampshire 40.7 /100k
6 New Jersey 25.9 /100k
7 Louisiana 16.6 /100k
8 Virginia 11.7 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
15 ml this page00065-0795-15 2,944 Rx · $215,892
500 ml00065-0795-50 610 Rx · $18,998
Drug total (last 4 qtrs): 3,554 Rx · 79,384 units · $234,891 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Bss — the program that covers self-administered drugs. 1 manufacturer.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Bss. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$139.63
Claims incl. refills
23
Beneficiaries
—
Spend / beneficiary
—
Spend / claim
$6.07
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

About this NDC listing & data coverage

Finished prescription product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data ✓ Available
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) ✓ Available
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Alcon Laboratories, Inc.. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 500 ml (00065-0795-50). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Alcon Laboratories, Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as a prescription product, so it is dispensed under a prescriber's order. Your pharmacist can tell you whether any over-the-counter forms of the same medication exist.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 00065-0741-14 · Alcon 00065-0800-50 · Alcon →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.